Bank Central Asia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,225 (market cap 753.61T, 180.06M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 2425.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (180.06M versus 159.2K). Which is the better fit depends on your goals.
| BBCA | DGNS | |
|---|---|---|
Market Cap | 753.61T | 310.75B |
Volume | 180.06M | 159.2K |
Lot | 1.8M | 1.59K |
Turnover | 1.11T | 34.72M |
Average Price | 6,176.89 | 218.06 |
Value | 1.11T | 34.72M |
Indicative Equilibrium Price | 6,225 | 220 |
Indicative Equilibrium Volume | 292.85K | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →